No. | Strain | Pathway Deficiency | Medium M9 | M9 + NA | M9 + NAD+ | M9 + NAM | ||||
---|---|---|---|---|---|---|---|---|---|---|
Expected | Observed | Expected | Observed | Expected | Observed | Expected | Observed | |||
1 | BW25113 | None | + | 65.8 | + | 49.8 | + | 50.5 | + | 49.4 |
2 | ΔnadC | dn | – | – | + | 49.4 | + | 49.4 | + | 53.4 |
3 | ΔnadC ΔpncA | dn, I | – | – | + | 50.3 | + | 49.2 | – | 380.8 |
4 | ΔnadC ΔpncA ΔxapA | dn, I | – | – | + | 49.2 | + | 50.0 | – | 620.4 |
5 | ΔnadC ΔpncA ΔxapA/pBAD-xapA | dn, I | – | NT | + | NT | + | + | – | 376.4 |
6 | ΔnadC ΔpncA ΔxapA/pBAD-EGFP | dn, I | – | NT | + | NT | + | + | – | 626.8 |
7 | ΔnadC ΔpncA ΔnadR | dn, I, III | – | – | + | 51.1 | + | NT | – | – |
8 | ΔnadC ΔpncA ΔxapA ΔnadR | dn, I, III | – | – | + | 49.7 | + | NT | – | – |